IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans
暂无分享,去创建一个
R. Xavier | S. Smeekens | L. Joosten | M. Netea | A. De Luca | C. Dinarello | T. Plantinga | M. Gresnigt | J. V. D. van der Meer | L. Romani | R. Iannitti | K. Conway | F. L. van de Veerdonk | G. Chamilos | J. Begun | A. Casagrande | Georgios Chamilos
[1] Jae U. Jung,et al. Regulation where autophagy intersects the inflammasome. , 2014, Antioxidants & redox signaling.
[2] James L. Mueller,et al. Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. , 2013, The Journal of clinical investigation.
[3] M. Netea,et al. Corticosteroids Block Autophagy Protein Recruitment in Aspergillus fumigatus Phagosomes via Targeting Dectin-1/Syk Kinase Signaling , 2013, The Journal of Immunology.
[4] C. Nathan,et al. Beyond oxidative stress: an immunologist's guide to reactive oxygen species , 2013, Nature Reviews Immunology.
[5] K. Kodys,et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. , 2012, The Journal of clinical investigation.
[6] R. Gavrieli,et al. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression , 2012, Expert review of anti-infective therapy.
[7] Jos W. M. van der Meer,et al. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.
[8] J. Latgé,et al. CD4(+) T cell vaccination overcomes defective cross-presentation of fungal antigens in a mouse model of chronic granulomatous disease. , 2012, The Journal of clinical investigation.
[9] A. Sher,et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction , 2012, Nature Immunology.
[10] R. Lutter,et al. Inflammation and repeated infections in CGD: two sides of a coin , 2011, Cellular and Molecular Life Sciences.
[11] T. Kuijpers,et al. Current Concepts of Hyperinflammation in Chronic Granulomatous Disease , 2011, Clinical & developmental immunology.
[12] L. Joosten,et al. Inflammasome-Independent Modulation of Cytokine Response by Autophagy in Human Cells , 2011, PloS one.
[13] M. Oosting,et al. Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 , 2011, Gut.
[14] M. Netea,et al. Anakinra for the inflammatory complications of chronic granulomatous disease. , 2011, The Netherlands journal of medicine.
[15] J. Tschopp,et al. Autophagy Controls IL-1β Secretion by Targeting Pro-IL-1β for Degradation , 2011, The Journal of Biological Chemistry.
[16] J. Orange,et al. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] A. Fischer,et al. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. , 2010, Blood.
[18] C. Antachopoulos. Invasive fungal infections in congenital immunodeficiencies. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] T. K. van den Berg,et al. Human NLRP3 inflammasome activation is Nox1-4 independent. , 2010, Blood.
[20] S. Smeekens,et al. Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease , 2010, Proceedings of the National Academy of Sciences.
[21] R. Xavier,et al. Crohn's disease‐associated adherent‐invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly , 2010, Cellular microbiology.
[22] C. Dinarello. Interleukin-1beta and the autoinflammatory diseases. , 2009, The New England journal of medicine.
[23] J. Brumell,et al. NADPH oxidases contribute to autophagy regulation , 2009, Autophagy.
[24] Irma Joosten,et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. , 2009, Cell host & microbe.
[25] Veronica Canadien,et al. Activation of antibacterial autophagy by NADPH oxidases , 2009, Proceedings of the National Academy of Sciences.
[26] S. Akira,et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.
[27] S. Bloom,et al. Phagocyte dysfunction and inflammatory bowel disease. , 2008, Inflammatory bowel diseases.
[28] S. Targan,et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. , 2008, Gastroenterology.
[29] J. Rioux,et al. Autophagy as an important process in gut homeostasis and Crohn’s disease pathogenesis , 2008, Gut.
[30] U. Grohmann,et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease , 2008, Nature.
[31] D. Green,et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis , 2007, Nature.
[32] Alastair Forbes,et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility , 2007, Nature Genetics.
[33] Z. Elazar,et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4 , 2007, The EMBO journal.
[34] Thomas Lengauer,et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.
[35] P. Hawkins,et al. Neutrophils from p40phox−/− mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing , 2006, The Journal of experimental medicine.
[36] S. Holland,et al. Gastrointestinal involvement in chronic granulomatous disease. , 2004, Pediatrics.
[37] Jeannie S. Huang,et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[38] M. Matsui,et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.
[39] A. Harken,et al. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] S. Holland,et al. Genetic, biochemical, and clinical features of chronic granulomatous disease. , 2000, Medicine.
[41] Richard B. Johnston,et al. Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.
[42] H. Mitomi,et al. Case Report: Colitis in Chronic Granulomatous Disease Resembling Crohn's Disease (Comparative Analysis of CD68-Positive Cells Between Two Disease Entities) , 1999, Digestive Diseases and Sciences.
[43] Y. Mahida,et al. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. , 1989, Gut.
[44] K. Rajagopalan,et al. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. , 1975, The Journal of clinical investigation.
[45] R. Good,et al. Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. , 1967, The Journal of clinical investigation.
[46] K. Mossman. The Wellcome Trust Case Control Consortium, U.K. , 2008 .
[47] Jeannie S. Huang,et al. Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.